Growing epidemic of coronary heart disease in low- and middle-income countries.

Coronary heart disease (CHD) is the single largest cause of death in the developed countries and is one of the leading causes of disease burden in developing countries. In 2001, there were 7.3 million deaths due to CHD worldwide. Three-fourths of global deaths due to CHD occurred in the low- and middle-income countries. The rapid rise in CHD burden in most of the low- and middle-income countries is due to socio-economic changes, increase in lifespan, and acquisition of lifestyle-related risk factors. The CHD death rate, however, varies dramatically across the developing countries. The varying incidence, prevalence, and mortality rates reflect the different levels of risk factors, other competing causes of death, availability of resources to combat cardiovascular disease, and the stage of epidemiologic transition that each country or region finds itself. The economic burden of CHD is equally large but solutions exist to manage this growing burden.

[1]  R Laurenti,et al.  Ischemic heart disease. Hospitalization, length of stay and expenses in Brazil from 1993 to 1997. , 2000, Arquivos brasileiros de cardiologia.

[2]  D. Levy,et al.  Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.

[3]  J. Rossouw,et al.  Community-based intervention: the Coronary Risk Factor Study (CORIS). , 1993, International journal of epidemiology.

[4]  Alan D. Lopez,et al.  Global burden of disease and risk factors , 2006 .

[5]  B. Popkin,et al.  The nutrition transition: worldwide obesity dynamics and their determinants , 2004, International Journal of Obesity.

[6]  C. la Vecchia,et al.  Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970–2000 , 2005, Heart.

[7]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[8]  E. Poskitt Countries in transition: underweight to obesity non-stop? , 2009, Annals of tropical paediatrics.

[9]  Milton C. Weinstein,et al.  Cost-Effectiveness Analysis of Hypertension Guidelines in South Africa: Absolute Risk Versus Blood Pressure Level , 2005, Circulation.

[10]  S. Olshansky,et al.  The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases. , 1986, The Milbank quarterly.

[11]  A. Mansur,et al.  Prescription and adherence to statins of patients with coronary artery disease and hypercholesterolemia. , 2001, Arquivos brasileiros de cardiologia.

[12]  B. Popkin,et al.  Trends in diet, nutritional status, and diet-related noncommunicable diseases in China and India: the economic costs of the nutrition transition. , 2009, Nutrition reviews.

[13]  Dean T. Jamison,et al.  Measuring the Global Burden of Disease and Risk Factors, 1990–2001 , 2006 .

[14]  R. Collins,et al.  Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.

[15]  Jesús Santos,et al.  Peripheral arterial disease in HIV patients older than 50 years of age. , 2008, AIDS research and human retroviruses.

[16]  Rajeev Gupta Burden of coronary heart disease in India. , 2005, Indian heart journal.

[17]  Rafael Emidio da Silva,et al.  Viable myocardium scintigraphy with intravenous nitroglycerine by computed tomography with Tc-99m (MIBI). , 2008, Arquivos brasileiros de cardiologia.

[18]  H. Ong,et al.  β blockers in hypertension and cardiovascular disease , 2007, BMJ : British Medical Journal.

[19]  R. Veras,et al.  The decline in mortality from circulatory diseases in Brazil. , 2009, Revista panamericana de salud publica = Pan American journal of public health.

[20]  Alan D. Lopez,et al.  Role of Smoking in Global and Regional Cardiovascular Mortality , 2005, Circulation.

[21]  D. Kromhout,et al.  Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. , 2006, European heart journal.

[22]  K. Reddy,et al.  Cardiovascular disease in non-Western countries. , 2004, The New England journal of medicine.

[23]  S. Kachboura,et al.  [The first Tunisian cardiovascular diseases register: processes and results]. , 2004, Revue d'epidemiologie et de sante publique.

[24]  Alan D. Lopez,et al.  Fatal and Nonfatal Cardiovascular Disease and the Use of Therapies for Secondary Prevention in a Rural Region of India , 2009, Circulation.

[25]  Eric Boerwinkle,et al.  An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. , 2006, Archives of internal medicine.

[26]  Stanton A Glantz,et al.  Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study , 2004, BMJ : British Medical Journal.

[27]  C. Seale Changing patterns of death and dying. , 2000, Social science & medicine.

[28]  S. Mendis,et al.  Prevention of cardiovascular disease in developing countries , 2007, The Lancet.

[29]  Alan D. Lopez,et al.  Mortality by cause for eight regions of the world: Global Burden of Disease Study , 1997, The Lancet.

[30]  E. C. Moura,et al.  Socioeconomic status and obesity in adult populations of developing countries: a review. , 2004, Bulletin of the World Health Organization.

[31]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[32]  B. Popkin,et al.  Overweight exceeds underweight among women in most developing countries. , 2005, The American journal of clinical nutrition.

[33]  S. Yusuf,et al.  Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. , 2001, Circulation.

[34]  M. Nsour,et al.  Prevalence and predictors of nonfatal myocardial infarction in Jordan. , 2008, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[35]  E. Feskens,et al.  Fall in total cholesterol concentration over five years in association with changes in fatty acid composition of cooking oil in Mauritius: cross sectional survey , 1996, BMJ.

[36]  N. Freemantle,et al.  Highlighting the need for better patient care in stable angina: results of the international Angina Treatment Patterns (ATP) Survey in 7074 patients. , 2004, Family practice.

[37]  Paul M. Ridker,et al.  Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women , 2007 .

[38]  A. Soltanian,et al.  The metabolic syndrome and nonfatal ischemic heart disease; a population-based study. , 2007, International journal of cardiology.

[39]  G. Assmann,et al.  Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.

[40]  J. Tuomilehto,et al.  Incidence, increasing prevalence, and predictors of change in obesity and fat distribution over 5 years in the rapidly developing population of Mauritius. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[41]  Dong Yaping Community health services in China: the experience of Tianjin City. , 2001 .

[42]  A. Coale,et al.  The demographic transition. , 1984, Pakistan development review.

[43]  Stanton A. Glantz,et al.  Cardiovascular Effects of Secondhand Smoke: Nearly as Large as Smoking , 2005, Circulation.

[44]  J. Pell,et al.  Smoke-free legislation and hospitalizations for acute coronary syndrome. , 2008, The New England journal of medicine.

[45]  Adam A. Leive,et al.  Financing global health: mission unaccomplished. , 2007, Health affairs.

[46]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[47]  A. Rodgers,et al.  Global burden of blood-pressure-related disease, 2001 , 2008, The Lancet.

[48]  Giuseppe Mancia,et al.  World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries. , 2007, Journal of hypertension.

[49]  S. Yusuf,et al.  Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study , 2006, The Lancet.

[50]  R. Collins,et al.  Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.

[51]  R. Califf,et al.  Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT. , 2000, European heart journal.

[52]  S. Mauss,et al.  Lipoprotein(a) in patients initiating antiretroviral therapy , 2008, HIV medicine.

[53]  R. Bhopal,et al.  Is coronary heart disease rising in India? A systematic review based on ECG defined coronary heart disease , 2005, Heart.

[54]  Li-sheng Liu Cardiovascular diseases in China. , 2007, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[55]  Colin Mathers,et al.  Comparative Quantification of Mortality and Burden of Disease Attributable to Selected Risk Factors , 2006 .

[56]  Jing Liu,et al.  Sino-MONICA Project: A Collaborative Study on Trends and Determinants in Cardiovascular Diseases in China, Part I: Morbidity and Mortality Monitoring , 2001, Circulation.

[57]  M. Gertler,et al.  Ischemic Heart Disease: Insulin, Carbohydrate, and Lipid Interrelationships , 1972, Circulation.

[58]  Jayanti Mukherjee,et al.  Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy. , 2005, The American journal of cardiology.

[59]  X. Zhang,et al.  Coronary heart disease in China , 2008, Heart.

[60]  G. Guindon,et al.  Tobacco control country profiles , 2003 .

[61]  S. Yusuf,et al.  WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE). , 2005, Bulletin of the World Health Organization.

[62]  Yang-feng Wu,et al.  Effect of Xuezhikang on Cardiovascular Events and Mortality in Elderly Patients with a History of Myocardial Infarction: A Subgroup Analysis of Elderly Subjects from the China Coronary Secondary Prevention Study , 2007, Journal of the American Geriatrics Society.

[63]  Murilo Foppa,et al.  Impacto econômico dos casos de doença cardiovascular grave no Brasil: uma estimativa baseada em dados secundários , 2008 .

[64]  R. Collins,et al.  Oral captopril versus placebo among 13 634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1) , 1995, The Lancet.

[65]  G Premalatha,et al.  Coronary Artery Disease Prevalence of Coronary Artery Disease and Its Relationship to Lipids in a Selected Population in South India The Chennai Urban Population Study (CUPS No. 5) , 2001 .

[66]  S. Leeder,et al.  Coronary heart disease epidemics: not all the same , 2008, Heart.

[67]  A. Barcelo,et al.  The cost of diabetes in Latin America and the Caribbean. , 2003, Bulletin of the World Health Organization.

[68]  A. Omran The epidemiologic transition. A theory of the epidemiology of population change. , 1971, The Milbank Memorial Fund quarterly.

[69]  V. Feigin,et al.  Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region , 2007, Journal of hypertension.

[70]  N. Cook,et al.  Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. , 2007, JAMA.

[71]  T. Gaziano,et al.  Cardiovascular Disease in the Developing World and Its Cost-Effective Management , 2005, Circulation.

[72]  E. Vartiainen,et al.  Changes in blood pressure, body mass index, and salt consumption in a Chinese population. , 1999, Preventive medicine.

[73]  Parvez Hossain,et al.  Obesity and diabetes in the developing world--a growing challenge. , 2007, The New England journal of medicine.

[74]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[75]  Ling Liu,et al.  Xuezhikang, An Extract of Cholestin, Reduces Cardiovascular Events in Type 2 Diabetes Patients With Coronary Heart Disease: Subgroup Analysis of Patients With Type 2 Diabetes From China Coronary Secondary Prevention Study (CCSPS) , 2007, Journal of cardiovascular pharmacology.

[76]  G. Balbinotto Neto,et al.  The costs of cardiovascular disease in Brazil: a brief economic comment. , 2008, Arquivos brasileiros de cardiologia.

[77]  E. Negri,et al.  Trends in mortality from major diseases in Europe, 1980–1993 , 2004, European Journal of Epidemiology.

[78]  Walter Willett,et al.  Changes in dietary fat and declining coronary heart disease in Poland: population based study , 2005, BMJ : British Medical Journal.

[79]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[80]  T. Jafar,et al.  Coronary artery disease epidemic in Pakistan: more electrocardiographic evidence of ischaemia in women than in men , 2007, Heart.

[81]  K. Reynolds,et al.  Global burden of obesity in 2005 and projections to 2030 , 2008, International Journal of Obesity.

[82]  L. Liu Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks. , 2001, Chinese Medical Journal.

[83]  Anoop Misra,et al.  Obesity and the metabolic syndrome in developing countries. , 2008, The Journal of clinical endocrinology and metabolism.

[84]  S. Leeder,et al.  Obesity and cardiovascular disease in developing countries: a growing problem and an economic threat , 2006, Current opinion in clinical nutrition and metabolic care.

[85]  J. Mackay,et al.  The Tobacco Atlas , 2002 .

[86]  S. Yusuf,et al.  Global burden of cardiovascular disease , 2007, Heart.

[87]  Milton C Weinstein,et al.  Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis , 2006, The Lancet.

[88]  C. Cannon,et al.  Treatment and outcomes of eastern Europeans with coronary syndromes in OPUS-TIMI 16. , 2005, International journal of cardiology.

[89]  R. Horton,et al.  Scaling up interventions for chronic disease prevention: the evidence , 2007, The Lancet.

[90]  Guilbert Jj The world health report 2002 - reducing risks, promoting healthy life. , 2003 .

[91]  G. Mensah Ischaemic heart disease in Africa , 2008, Heart.

[92]  P. Wolf,et al.  Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2006, Circulation.

[93]  J. Ware The limitations of risk factors as prognostic tools. , 2006, The New England journal of medicine.

[94]  R. Collins,et al.  Cigarette smoking, tar yields, and non-fatal myocardial infarction : 14000 cases and 32000 controls in the United Kingdom , 1995 .

[95]  Garrett Fitzmaurice,et al.  Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort , 2008, The Lancet.

[96]  A. Leiman,et al.  The direct and indirect costs of cardiovascular disease in South Africa in 1991. , 1996, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[97]  D. Jamison,et al.  Tobacco Addiction -- Disease Control Priorities in Developing Countries , 2006 .

[98]  S. Mohiuddin,et al.  Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. , 2007, Chest.

[99]  S. Yusuf,et al.  The burden of cardiovascular disease in the Indian subcontinent. , 2006, The Indian journal of medical research.

[100]  J. Powles,et al.  Ecological study of reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991 , 1998, BMJ.

[101]  M. Geraedts,et al.  Quality of care of patients with acute myocardial infarction in Bulgaria: a cross-sectional study , 2009, BMC health services research.

[102]  R. Collins,et al.  Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14,000 cases and 32,000 controls in the United Kingdom. The International Studies of Infarct Survival (ISIS) Collaborators. , 1995, BMJ.

[103]  K. Reddy,et al.  Burden of non-communicable diseases in South Asia , 2004, BMJ : British Medical Journal.

[104]  C. Murray,et al.  Household catastrophic health expenditure: a multicountry analysis , 2003, The Lancet.

[105]  M. Khalil,et al.  Coronary artery disease in Saudi Arabia. , 2004, Saudi medical journal.

[106]  Salvatore Panico,et al.  Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. , 2005, International journal of epidemiology.

[107]  D. Jamison,et al.  Disease Control Priorities in Developing Countries , 1993 .